TransMedics Group (TMDX) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $94.00 from $95.00 | Oct 13, 2026 |
| Barclays | Initiated Coverage | Overweight | $120.00 | Oct 7, 2026 |
| TD Cowen | Maintained | Buy | $120.00 | Sep 8, 2026 |
| Piper Sandler | Maintained | Overweight | $100.00 from $120.00 | Aug 5, 2026 |
| UBS | Maintained | Neutral | $77.00 from $80.00 | Aug 5, 2026 |
| Needham | Maintained | Buy | $106.00 from $142.00 | Aug 3, 2026 |
| UBS | Initiated Coverage | Neutral | $80.00 | Jul 28, 2026 |
| Evercore ISI Group | Maintained | Outperform | $90.00 from $100.00 | Jul 6, 2026 |
| TD Cowen | Maintained | Buy | $120.00 | Jul 1, 2026 |
| Canaccord Genuity | Maintained | Buy | $124.00 | Jun 30, 2026 |
| Stifel | Maintained | Hold | $80.00 from $75.00 | Jun 18, 2026 |
| Stifel | Maintained | Hold | $75.00 from $85.00 | May 26, 2026 |
| Needham | Maintained | Buy | $142.00 from $174.00 | May 6, 2026 |
| Piper Sandler | Maintained | Overweight | $120.00 from $160.00 | May 6, 2026 |
| Stifel | Maintained | Hold | $85.00 from $130.00 | May 6, 2026 |
| TD Cowen | Maintained | Buy | $120.00 from $190.00 | May 6, 2026 |
| Canaccord Genuity | Maintained | Buy | $124.00 from $152.00 | May 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $118.00 from $170.00 | Apr 6, 2026 |
| Stifel | Maintained | Hold | $130.00 from $115.00 | Mar 9, 2026 |
| Needham | Maintained | Buy | $174.00 from $166.00 | Feb 25, 2026 |
Frequently asked questions
What is the price target for TMDX stock?
The average 12-month analyst price target for TransMedics Group (TMDX) is $102.83, with a high estimate of $120.00 and a low of $77.00, across 6 analysts.
Is TMDX a buy, sell, or hold?
Analysts covering TransMedics Group currently average a Buy rating: 8 buy, 4 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for TMDX?
The average price target of $102.83 implies 36.17% upside from the last price of $75.52.
What is the latest analyst rating on TMDX?
On Oct 13, 2026, Canaccord Genuity maintained TransMedics Group at Buy with a price target of $94.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.